1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neutrophil Gelatinase-associated Lipocalin Test Kit by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neutrophil Gelatinase-associated Lipocalin Test Kit by Country/Region, 2018, 2022 & 2029
2.2 Neutrophil Gelatinase-associated Lipocalin Test Kit Segment by Type
2.2.1 Immunochromatography
2.2.2 Colloidal Gold Method
2.3 Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Type
2.3.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Sales Market Share by Type (2018-2023)
2.3.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Sale Price by Type (2018-2023)
2.4 Neutrophil Gelatinase-associated Lipocalin Test Kit Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Application
2.5.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Sale Market Share by Application (2018-2023)
2.5.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Sale Price by Application (2018-2023)
3 Global Neutrophil Gelatinase-associated Lipocalin Test Kit by Company
3.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Breakdown Data by Company
3.1.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Sales by Company (2018-2023)
3.1.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Sales Market Share by Company (2018-2023)
3.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Revenue by Company (2018-2023)
3.2.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue by Company (2018-2023)
3.2.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue Market Share by Company (2018-2023)
3.3 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Sale Price by Company
3.4 Key Manufacturers Neutrophil Gelatinase-associated Lipocalin Test Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neutrophil Gelatinase-associated Lipocalin Test Kit Product Location Distribution
3.4.2 Players Neutrophil Gelatinase-associated Lipocalin Test Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neutrophil Gelatinase-associated Lipocalin Test Kit by Geographic Region
4.1 World Historic Neutrophil Gelatinase-associated Lipocalin Test Kit Market Size by Geographic Region (2018-2023)
4.1.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neutrophil Gelatinase-associated Lipocalin Test Kit Market Size by Country/Region (2018-2023)
4.2.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neutrophil Gelatinase-associated Lipocalin Test Kit Sales Growth
4.4 APAC Neutrophil Gelatinase-associated Lipocalin Test Kit Sales Growth
4.5 Europe Neutrophil Gelatinase-associated Lipocalin Test Kit Sales Growth
4.6 Middle East & Africa Neutrophil Gelatinase-associated Lipocalin Test Kit Sales Growth
5 Americas
5.1 Americas Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Country
5.1.1 Americas Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Country (2018-2023)
5.1.2 Americas Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue by Country (2018-2023)
5.2 Americas Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Type
5.3 Americas Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Region
6.1.1 APAC Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Region (2018-2023)
6.1.2 APAC Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue by Region (2018-2023)
6.2 APAC Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Type
6.3 APAC Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neutrophil Gelatinase-associated Lipocalin Test Kit by Country
7.1.1 Europe Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Country (2018-2023)
7.1.2 Europe Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue by Country (2018-2023)
7.2 Europe Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Type
7.3 Europe Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neutrophil Gelatinase-associated Lipocalin Test Kit by Country
8.1.1 Middle East & Africa Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neutrophil Gelatinase-associated Lipocalin Test Kit Revenue by Country (2018-2023)
8.2 Middle East & Africa Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Type
8.3 Middle East & Africa Neutrophil Gelatinase-associated Lipocalin Test Kit Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neutrophil Gelatinase-associated Lipocalin Test Kit
10.3 Manufacturing Process Analysis of Neutrophil Gelatinase-associated Lipocalin Test Kit
10.4 Industry Chain Structure of Neutrophil Gelatinase-associated Lipocalin Test Kit
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neutrophil Gelatinase-associated Lipocalin Test Kit Distributors
11.3 Neutrophil Gelatinase-associated Lipocalin Test Kit Customer
12 World Forecast Review for Neutrophil Gelatinase-associated Lipocalin Test Kit by Geographic Region
12.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Market Size Forecast by Region
12.1.1 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Forecast by Region (2024-2029)
12.1.2 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Forecast by Type
12.7 Global Neutrophil Gelatinase-associated Lipocalin Test Kit Forecast by Application
13 Key Players Analysis
13.1 Easydiagnosis
13.1.1 Easydiagnosis Company Information
13.1.2 Easydiagnosis Neutrophil Gelatinase-associated Lipocalin Test Kit Product Portfolios and Specifications
13.1.3 Easydiagnosis Neutrophil Gelatinase-associated Lipocalin Test Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Easydiagnosis Main Business Overview
13.1.5 Easydiagnosis Latest Developments
13.2 Biosino
13.2.1 Biosino Company Information
13.2.2 Biosino Neutrophil Gelatinase-associated Lipocalin Test Kit Product Portfolios and Specifications
13.2.3 Biosino Neutrophil Gelatinase-associated Lipocalin Test Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biosino Main Business Overview
13.2.5 Biosino Latest Developments
13.3 3V
13.3.1 3V Company Information
13.3.2 3V Neutrophil Gelatinase-associated Lipocalin Test Kit Product Portfolios and Specifications
13.3.3 3V Neutrophil Gelatinase-associated Lipocalin Test Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 3V Main Business Overview
13.3.5 3V Latest Developments
14 Research Findings and Conclusion
※参考情報 好中球ゼラチナーゼ結合性リポカリン(NGAL)は、体内で発生するタンパク質であり、主に好中球と呼ばれる白血球から分泌されることが知られています。NGALは、その生理的な役割だけでなく、病的状態におけるマーカーとしての重要性から、医療においても注目を浴びています。ここではNGALに関する検査キットの概念について、定義、特徴、種類、用途、および関連技術について詳しく説明いたします。 NGALは体内の急性炎症反応や細胞死に応じて迅速に上昇するため、特に腎不全や急性腎障害(AKI)の早期診断において重要なバイオマーカーとされています。急性腎障害は、さまざまな病因によって発症し、早期に治療を行わないと、重篤な合併症や死亡に至ることがあります。そのため、早期に病状を察知することが求められています。 NGALの検出に用いられる検査キットは、その特異性や感度によって分類されることが一般的です。これらの検査キットは、主に血清や尿中のNGALを測定することが目的とされています。尿中NGALの濃度は、腎臓の機能障害を早期に発見する上で有用です。特に、他の腎機能マーカーと比較して、NGALは急性腎障害をより早期に検知する能力を持つとされています。 NGAL検査キットの大きな特徴としては、簡便性と迅速性があります。一般的な試験方法は、ELISA(酵素結合免疫吸着測定法)に基づいており、特異的な抗体を用いてNGALを検出します。この手法により、短時間で結果を得ることができるため、病院や診療所での即時診断に適しています。また、さまざまな分野での利用が期待され、特に腎臓内科や集中治療室での使用が増えています。 NGALの測定は、急性腎障害の評価だけでなく、心血管疾患やがんの予後予測など多様な疾患に対する研究も行われています。最近の研究では、NGALが心筋梗塞後の腎機能予後や、感染症における重症度指標としての可能性も示唆されています。このことから、NGALの測定は、従来の腎機能評価だけではなく、さまざまな病態の理解にも寄与することが期待されています。 関連技術としては、NGALを計測するための新しいバイオセンサーや、マイクロ流体デバイスの研究も進行中です。これにより、より低侵襲で迅速な検査が可能となることが期待されています。また、NGALの遺伝子や特性を調べる研究が進められ、これに基づく個別化医療の実現への期待も高まっています。 以上のように、好中球ゼラチナーゼ結合性リポカリン検査キットは、腎障害やその他の病態の早期発見に有効な手段として、その重要性が高まっています。今後の研究成果や技術開発によって、より多くの疾患に対する理解が進み、より良い医療サービスの提供につながることが期待されます。NGALはその特異性及び感度から、今後の診断技術における革新をもたらす存在となるでしょう。このように、好中球ゼラチナーゼ結合性リポカリンは、臨床現場においてますます重要な役割を果たすことになると考えられます。 |